EMERSON PERIN to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications EMERSON PERIN has written about Cell- and Tissue-Based Therapy.
Connection Strength
1.836
-
From state-of-the-art cell therapy to endogenous cardiac repair. EuroIntervention. 2017 Aug 25; 13(6):760-772.
Score: 0.502
-
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells). Circulation. 2017 Apr 11; 135(15):1417-1428.
Score: 0.484
-
Autologous cell-based therapy for ischemic heart disease: clinical evidence, proposed mechanisms of action, and current limitations. Catheter Cardiovasc Interv. 2009 Feb 15; 73(3):281-8.
Score: 0.278
-
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor?Cell Therapy in Patients With?Heart?Failure. J Am Coll Cardiol. 2023 03 07; 81(9):849-863.
Score: 0.184
-
Recommendations for nomenclature and definition of cell products intended for human cardiovascular use. Cardiovasc Res. 2022 08 24; 118(11):2428-2436.
Score: 0.177
-
Implementation of cardovascular cell therapy network trials: challenges, innovation and lessons learned from experience in the CCTRN. Expert Rev Cardiovasc Ther. 2013 Nov; 11(11):1495-502.
Score: 0.096
-
Cell therapy for heart failure: lessons learned from SCIENCE. Eur J Heart Fail. 2023 04; 25(4):588-590.
Score: 0.046
-
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies. ESC Heart Fail. 2021 06; 8(3):2306-2309.
Score: 0.040
-
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial. Cell Transplant. 2016; 25(9):1675-1687.
Score: 0.028